(lp0
S'Stock Returns: Vical Incorporated  versus XOMA Corporation ... CML News - Apr 16, 2017 This is a snapshot to compare the stock returns for Vical Incorporated  versus XOMA Corporation  .Analysts Set $8.00 Price Target for Vical Incorporated  - Sports PerspectivesWhich Analysts Are Watching Vical Incorporated ? - Fiscal Standard'
p1
aS"Trading Options During Earnings in Vical Incorporated  CML News - Apr 16, 2017 We're going to examine buying and selling out of the money strangles in Vical Incorporated and find out once and for all what the winning trades have been during earnings releases."
p2
aS'VICAL INCORPORATED  Files An 8-K Other Events Market Exclusive - Apr 4, 2017 On April 4, 2017, Vical Incorporated entered into a research collaboration agreement with AnGes MG, Inc. . to the collaboration agreement, AnGes agreed to provide funding for the program up to a specified limit and we agreed to conduct certain&nbsp;...'
p3
aS'Insider Trading Activity Vical Incorporated   VP Sold 4250 ... Market Exclusive - Mar 29, 2017 On 8/31/2012 James R Singer, Major Shareholder, bought 310,000 with an average share price of $3.51 per share and the total transaction amounting to $1,088,100.00.'
p4
aS'Trading Covered Calls: Vical Incorporated  : Covered Calls ... CML News - Apr 16, 2017 As we look at Vical Incorporated we note that a covered call is one of the most common implementations of an option strategy, but the analysis completed when employing the covered call often times lacks the necessary rigor especially surrounding earnings.'
p5
aS'Vical Reports Fourth Quarter 2016 Financial Results GlobeNewswire  - Mar 9, 2017 SAN DIEGO, March 09, 2017  -- Vical Incorporated  today reported financial results for the three and twelve months ended December 31, 2016.How Often Does Vical Incorporated  Beat Earnings Estimates? - Post Analyst'
p6
aS'Vical and Astellas Announce Topline Results from a Phase 2 Study of ... GlobeNewswire  - Sep 19, 2016 SAN DIEGO and TOKYO, Sept. 19, 2016  -- Vical Incorporated  and Astellas Pharma Inc.  today announced topline results from a randomized, double-blind, placebo-controlled Phase 2 study evaluating the&nbsp;...Vical, Astellas report miss in kidney transplant study with cytomegalovirus ... - BioWorld Online'
p7
aS"Vical's Herpes Vaccine: An Update Seeking Alpha - Sep 12, 2013 With the failure of its Allovectin immunotherapy for multiple melanoma and the refocus of the company's resources on vaccines, Vical  finally provided some long-awaited information on the forthcoming Phase 1/2 trial of the company's herpes&nbsp;..."
p8
aS'Zacks: Vical Incorporated  Given $8.00 Average Price Target by Analysts The Cerbat Gem - Apr 11, 2017 Vical logo Vical Incorporated  has received an average broker rating score of 1.00  from the one analysts that cover the company, Zacks Investment Research reports.Vical Incorporated  Valuation According To Analysts - UK Market News'
p9
aS"Vical Incorporated  Announces Quarterly Earnings Results The Cerbat Gem - Mar 31, 2017 Vical logo Vical Incorporated  issued its quarterly earnings data on Thursday. The company reported  earnings per share  for the quarter, missing the Thomson Reuters' consensus estimate of  by $0.04.Vical Incorporated  Issues Earnings Results, Misses Expectations By $0 ... - Sports Perspectives"
p10
a.